WWARN’s scientific work is structured by five Scientific Groups focused on fields of expertise that are integral to our understanding of antimalarial drug resistance. The Clinical, Pharmacology, In-Vitro, MolecularMedicine Quality and Malaria in Pregnancy Groups. The Scientific Groups provide a collaborative platform to enable us to work with research institutes, pharmaceutical companies and modellers to further our understanding of the spread of malaria drug resistance.

Our scientific pursuits:

  • Clinical- increasing the extent of antimalarial clinical data available to the research and healthcare community, improving capacity in endemic countries to provide reliable evidence of malaria drug resistance.
  • Pharmacology - reducing drug resistance by informing optimal antimalarial dosing in key target populations, such as pregnant women and children. The team are also working to differentiate true antimalarial resistance from inadequate drug exposure.
  • In Vitro - developing new laboratory methods and tools, providing training on how to use these techniques and ensuring quality assurance controls. The team support researchers from endemic countries to strengthen their skills and know-how to provide further evidence on the scale and spread of antimalarial drug resistance.
  • Molecular - increasing the availability of molecular data by collecting, collating and displaying patterns of drug resistant malaria markers to help inform prevention strategies. 
  • Medicine Quality - collating information to increase our understanding of the prevalence and distribution of counterfeit and substandard medicines, including antimalarials a key contributing factor to the spread of antimalarial drug resistance.
  • Malaria in Pregnancytracking the severity and spread of antimalarial drug resistance and develop a better understanding of the impact of drug resistance on the efficacy of intermittent preventive treatment (IPT) strategies to control malaria in pregnancy. 

Find out more about our Scientific Groups.